AndhraNews.net
Home » Business News » 2011 » June » June 8, 2011

Expert Briefing: What Investors Should Know About Tight Glycemic Control and Its Future


June 8, 2011 - LOS ANGELES, CA

Stanley A. Nasraway, Jr., M.D., F.C.C.M, a member of the Scientific Advisory Board of Echo Therapeutics, Inc (OTCBB: ECTE) has published an Expert Briefing titled: "Tight Glycemic Control: What do we really know, and what should we expect?"

Tight glycemic control in hospital patients has engendered large numbers of clinical investigations, with conflicting results. The world has largely embraced intensive insulin as a practice, but applies this with great variability in the manner of glucose control and measurement. After numerous studies, what do we actually know with certainty, and what we can expect looking forward?

Echo Therapeutics is currently developing its Symphony tCGM System, which has been tested at the Tufts Medical Center in Boston where Dr. Nasraway is the Director of the Surgical Intensive Care Units. The breakthrough Symphony tCGM System is a non-invasive, wireless, transdermal continuous glucose monitoring system (tCGM) that may be used for both hospital patients and for outpatient diabetics.

The special report about improving the accuracy of blood glucose measurements and increasing the frequency of measurements by using continuous monitors and what it could mean to investors and Echo Therapeutics is available now at: http://biomedreports.com/tight-glycemic-control-what-do-we-really-know-and-what-should-we-expect.html

In addition, investors interested in accessing BioMedReports' new complete database of clinical trials and upcoming FDA and world-wide regulatory decisions which can be used to make more profitable trades can go to: http://biomedreports.com/access-our-exclusive-fda-and-clinical-trials-calendars.html

News developments and live healthcare sector updates are available constantly via Twitter at: http://twitter.com/BioMedReports

About BioMedReports.Com

BioMedReports is a news portal covering the biomedical news and financial sector. BioMedReports is not paid or compensated to report the news and developments of publicly traded companies in the healthcare sector of the markets. Full disclosures and information about these stocks and news are available at BioMedReports.Com

Add to Digg Bookmark with del.icio.us Add to Newsvine

Media Contacts Only:
Mary Davila
Assistant Editor, BioMedReports.Com
e-mail: Email Contact
Tel: +1 323 472 4480
Fax: +1 888 210 3556

MarketWire

Comment on this story

Share